Results 221 to 230 of about 637,784 (267)
Some of the next articles are maybe not open access.
Economics of Chronic Heart Failure
European Journal of Heart Failure, 2001Abstract Chronic heart failure (CHF) is now recognized as a major and escalating public health problem. The costs of this syndrome, both in economic and personal terms, are considerable. The prevalence of CHF is 1–2% and appears to be increasing, in part because of ageing of the population. Economic analyses of CHF should include both
C, Berry, D R, Murdoch, J J, McMurray
openaire +2 more sources
Pediatric Critical Care Medicine, 2016
Objectives: The objectives of this review are to discuss the paradigms used to stage heart failure in children, the classification and physiologic profile of cardiomyopathies, and the acute and chronic pharmacologic management of heart failure. Data Source: MEDLINE, PubMed.
openaire +2 more sources
Objectives: The objectives of this review are to discuss the paradigms used to stage heart failure in children, the classification and physiologic profile of cardiomyopathies, and the acute and chronic pharmacologic management of heart failure. Data Source: MEDLINE, PubMed.
openaire +2 more sources
Hyponatremia in Chronic Heart Failure
Kardiologiia, 2014Hyponatremia - lowering of sodium in blood serum below 135 mmol/l - is a frequent disorder of electrolyte metabolism in patients with chronic heart failure (CHF). Hyponatremia is a risk factor of elevated mortality, repetitive hospitalizations, and worsening of kidney function in patients with decompensation of CHF.
D Iu, Shchekochikhin +3 more
openaire +2 more sources
An overview of chronic heart failure
Nursing Standard, 2023Heart failure (HF) is associated with high morbidity and mortality and is a significant public health concern. Globally, the prevalence of HF is increasing and prognosis remains suboptimal for people with the condition. HF has significant effects on patients, their families and healthcare services. People with HF can present with acute or chronic signs
Jyoti Shrestha, Sarah Done
openaire +4 more sources
Telomeres and Chronic Heart Failure
Kardiologiia, 2014With age, a person's cardio-vascular system changes gradually formed at different functional levels, which are the basis for the development of chronic heart failure. While aging itself does not lead to chronic heart failure, it is likely that age-related changes in the human body can accelerate the time onset of signs and symptoms of the disease ...
O M, Drapkina, R N, Shepel'
openaire +2 more sources
Erythropoietin in Chronic Heart Failure
Congestive Heart Failure, 2007In patients with chronic heart failure (CHF), anemia is common and is associated with adverse outcome. Correction of anemia by erythropoiesis‐stimulating proteins would thus seem attractive. Endogenous erythropoietin (Epo) levels are increased in CHF and are associated with severity of the disease and with increased mortality.
Anne M S, Belonje +3 more
openaire +2 more sources
Homocysteine in Chronic Heart Failure
Clinical Laboratory, 2015Hyperhomocysteinemia (HHcy) is a risk factor for cardiovascular disease. Homocysteine (Hcy) can generate reactive oxygen species. Oxidative stress enhances the progression of cardiovascular diseases and has long been implicated in chronic heart failure (CHF).
Pauline, Fournier +5 more
openaire +2 more sources
Testosterone in Chronic Heart Failure
2008Chronic heart failure is common and can be described as a syndrome characterized by impairment of cardiac function associated with a maladaptive metabolic and neurohormonal axis. The thesis that testosterone replacement therapy may be helpful as a treatment for chronic heart failure may seem at first to be unlikely.
C, Malkin, T, Jones, K, Channer
openaire +2 more sources
Quinapril in Chronic Heart Failure
American Journal of Hypertension, 1990Angiotensin converting enzyme inhibitors are now firmly established in the treatment of patients with chronic heart failure (CHF). Their beneficial acute and chronic hemodynamic effects are not associated with reflex tachycardia or drug tolerance. Angiotensin converting enzyme inhibitors produce symptomatic improvement and improve exercise capacity in ...
D B, Northridge, H J, Dargie
openaire +2 more sources
Pathophysiology of chronic heart failure
The American Journal of Medicine, 2001Heart failure is a changing paradigm. The hemodynamic model, which served our needs well from the 1950s through the early 1980s, has now been largely abandoned, except for the management of decompensated patients in the hospital. The pathophysiology is exceedingly complex and involves structural changes, such as loss of myofilaments, apoptosis and ...
openaire +2 more sources